A review of uses of health care utilization databases for epidemiologic research on therapeutics.

By Sebastian Schneeweiss, J. Avorn. Journal of Clinical Epidemiology, 2005

1,320 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Feasibility and utility of applications of the common data model to multiple, disparate observational health databases (2015, background): “Specifically, we identified all new users of each target drug (warfarin and rivaroxaban) who satisfied the following 7 criteria of the original study: (1) had at least 183 days of nonexposure before the first target drug exposure; (2) had at least 1 atrial fibrillation or atrial flutter diagnosis co”
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study (2017, methodology): “32 33 47 This method uses a within person approach to compare the rates of events after corticosteroid use (5-30 days and 31-90 days after the prescription was filled) with the rates before use (see web appendix figure 1).”
Data Resource Profile: The Danish National Prescription Registry (2016, background): “Other data sources, such as those based on American health maintenance organizations, may have coverage beyond 20 years, but most have large annual turnover in beneficiaries.(40) In studies using the NPR, loss to follow-up is caused only by emigration, which can be traced through the Danish Civil Re”
Novel Data Mining Methodologies for Adverse Drug Event Discovery and Analysis (2012, background): “10,26,27 In the recent past, researchers have begun to focus on data and information sources that have not traditionally been used for PhV.”